Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)

(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide) is listed in the pharmaceutical impurity collection under CAS 195454-31-0. Its represented structure has formula C28H27NO5S and a calculated molecular weight of 489.59 g/mol.

2D chemical structure

O O N + O - O H S O H

Chemical identity

Catalog name
(6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)
Common name
Not available
Chemical name
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-[2-(1-oxidopiperidin-1-ium-1-yl)ethoxy]phenyl]methanone
CAS
195454-31-0
SMILES
O=C(c1ccc(OCC[N+]2([O-])CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
InChI
InChI=1S/C28H27NO5S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)35-28)27(32)19-6-11-23(12-7-19)34-17-16-29(33)14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2
InChIKey
KNADIZJVEMEXLS-UHFFFAOYSA-N
Associated API
Raloxifene Hydrochloride

Record ID: Af3adbe77dbfe

Computed properties

C28H27NO5S Molecular formula
489.593 g/molMolecular weight
489.161 DaMonoisotopic exact mass
89.82 ŲTopological polar surface area
6.0878 Calculated LogP (Wildman–Crippen)
138.0395 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O S 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight489.59383.99
Calculated LogP (Wildman–Crippen)6.087894.98
Topological polar surface area89.8265.23
Hydrogen-bond acceptors675.83
Hydrogen-bond donors264.87
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC28H27NO5Sdimensionless
Molecular weight489.593g/mol
Monoisotopic exact mass489.161Da
Topological polar surface area89.82Ų
Calculated LogP (Wildman–Crippen)6.0878dimensionless
Molar refractivity (Wildman–Crippen)138.0395cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors2count
Rotatable bonds (strict)7count
Heavy atoms35count
Heteroatoms7count
Rings5count
Aromatic rings4count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles3count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.25fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area207.3629Ų
Valence electrons180count
Radical electrons0count
Bertz complexity1,338.5428index
Balaban J1.3844index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)

Qualification and safety assessment of (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)

Explore toxicological qualification of (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide) and ICH M7 mutagenic impurity assessment of (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide) and acceptable intake and limit justification for (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for (6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl)[4-[2-(piperidin-1-yl)ethoxy]phenyl]methanone N-Oxide (Raloxifene N-Oxide)

Explore Altox services and software through the Altox Pharma-Hub.